A detailed history of Dimensional Fund Advisors LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 657,176 shares of ARVN stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
657,176
Previous 463,935 41.65%
Holding current value
$12.3 Million
Previous $12.3 Million 31.07%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$23.66 - $32.73 $4.57 Million - $6.32 Million
193,241 Added 41.65%
657,176 $16.2 Million
Q2 2024

Aug 09, 2024

BUY
$24.46 - $40.4 $724,872 - $1.2 Million
29,635 Added 6.82%
463,935 $12.3 Million
Q1 2024

May 10, 2024

SELL
$36.38 - $52.31 $2.09 Million - $3.01 Million
-57,577 Reduced 11.71%
434,300 $17.9 Million
Q4 2023

Feb 07, 2024

BUY
$14.19 - $42.33 $318,977 - $951,536
22,479 Added 4.79%
491,877 $20.2 Million
Q3 2023

Nov 09, 2023

BUY
$19.64 - $28.21 $5.04 Million - $7.24 Million
256,689 Added 120.68%
469,398 $9.22 Million
Q2 2023

Aug 09, 2023

BUY
$21.73 - $31.43 $812,093 - $1.17 Million
37,372 Added 21.31%
212,709 $5.28 Million
Q1 2023

May 12, 2023

BUY
$26.15 - $37.26 $4.59 Million - $6.53 Million
175,337 New
175,337 $4.79 Million
Q2 2022

Aug 12, 2022

SELL
$36.01 - $74.24 $388,908 - $801,792
-10,800 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$60.27 - $81.57 $3.48 Million - $4.71 Million
-57,740 Reduced 84.24%
10,800 $727,000
Q4 2021

Feb 09, 2022

SELL
$65.85 - $96.21 $4.39 Million - $6.42 Million
-66,690 Reduced 49.32%
68,540 $5.63 Million
Q3 2021

Nov 12, 2021

BUY
$73.2 - $107.87 $2.7 Million - $3.98 Million
36,927 Added 37.56%
135,230 $11.1 Million
Q2 2021

Aug 12, 2021

BUY
$60.45 - $84.26 $2.61 Million - $3.64 Million
43,161 Added 78.27%
98,303 $7.57 Million
Q1 2021

May 14, 2021

SELL
$58.19 - $91.37 $84,491 - $132,669
-1,452 Reduced 2.57%
55,142 $3.64 Million
Q4 2020

Feb 25, 2021

BUY
$20.19 - $84.93 $1.14 Million - $4.81 Million
56,594 New
56,594 $4.8 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $997M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.